Nanalysis Scientific Financials
NSCI Stock | CAD 0.31 0.01 3.33% |
Operating Margin (0.09) | Profit Margin (0.33) | Short Ratio 0.49 | EPS Estimate Current Year (0.04) | Return On Equity (0.38) |
Nanalysis | Select Account or Indicator |
Please note, the imprecision that can be found in Nanalysis Scientific's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Nanalysis Scientific Corp. Check Nanalysis Scientific's Beneish M Score to see the likelihood of Nanalysis Scientific's management manipulating its earnings.
Nanalysis Scientific Stock Summary
Nanalysis Scientific competes with ISign Media, Cogeco Communications, Canlan Ice, Algoma Steel, and Overactive Media. Nanalysis Scientific Corp., through its subsidiary, Nanalysis Corp., operates as an industrial technology company. The company sells its instruments in approximately 40 countries. NANALYSIS SCIENTIFIC operates under Scientific Technical Instruments classification in Canada and is traded on TSX Venture Exchange.Foreign Associate | UK |
Specialization | Information Technology, Scientific & Technical Instruments |
Instrument | Canada Stock View All |
Exchange | TSX Venture Exchange |
ISIN | CA63000Y1034 |
Business Address | Bay 1, 4600 |
Sector | Electronic Equipment, Instruments & Components |
Industry | Information Technology |
Benchmark | Dow Jones Industrial |
Website | www.nanalysis.com |
Phone | 403 769 9499 |
Currency | CAD - Canadian Dollar |
You should never invest in Nanalysis Scientific without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Nanalysis Stock, because this is throwing your money away. Analyzing the key information contained in Nanalysis Scientific's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Nanalysis Scientific Key Financial Ratios
There are many critical financial ratios that Nanalysis Scientific's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Nanalysis Scientific Corp reports annually and quarterly.Revenue | 28.47 M | ||||
Gross Profit | 10.24 M | ||||
EBITDA | (9.08 M) | ||||
Net Income | (16.78 M) | ||||
Total Asset | 53.82 M |
Nanalysis Scientific Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 18.3M | 24.0M | 37.8M | 69.9M | 53.8M | 31.5M | |
Other Current Liab | 705K | 2.6M | 2.0M | 810K | 428K | 406.6K | |
Net Tangible Assets | 7.9M | 14.5M | 13.8M | 22.0M | 25.2M | 26.5M | |
Retained Earnings | (4.2M) | (7.9M) | (9.7M) | (18.8M) | (35.0M) | (33.2M) | |
Accounts Payable | 678K | 2.6M | 4.4M | 5.8M | 5.1M | 3.0M | |
Cash | 6.6M | 3.2M | 10.4M | 3.5M | 759K | 721.1K | |
Other Assets | 3.8M | 5.9M | 12.1M | 12.5M | 14.4M | 15.1M | |
Long Term Debt | 1.0M | 2.8M | 2.7M | 3.8M | 12.6M | 13.2M | |
Net Receivables | 2.6M | 1.8M | 5.0M | 6.1M | 8.3M | 4.4M | |
Inventory | 857K | 2.8M | 3.7M | 7.4M | 5.8M | 3.2M | |
Total Liab | 3.2M | 9.6M | 13.8M | 22.3M | 30.3M | 31.9M | |
Short Long Term Debt | 116K | 209K | 1.9M | 3.7M | 6.5M | 6.8M | |
Total Current Assets | 10.2M | 9.4M | 20.8M | 22.0M | 17.9M | 12.8M | |
Intangible Assets | 6.5M | 12.7M | 14.1M | 26.6M | 15.9M | 11.1M | |
Common Stock | 10.0M | 18.3M | 20.7M | 31.3M | 36.0M | 37.8M | |
Net Invested Capital | 16.3M | 17.4M | 28.6M | 42.6M | 42.5M | 28.7M | |
Capital Stock | 18.3M | 20.7M | 31.3M | 49.0M | 53.2M | 33.4M | |
Net Working Capital | 8.5M | 3.0M | 12.1M | 8.4M | 3.3M | 3.2M |
Nanalysis Scientific Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Revenue | 8.4M | 7.9M | 16.0M | 24.8M | 28.5M | 14.7M | |
Gross Profit | 6.1M | 5.2M | 10.2M | 10.5M | 4.0M | 6.8M | |
Operating Income | 66K | (3.7M) | (1.2M) | (9.9M) | (13.5M) | (12.8M) | |
Ebit | 288K | 58K | (3.7M) | (1.2M) | (1.1M) | (1.0M) | |
Cost Of Revenue | 2.3M | 2.7M | 5.8M | 14.4M | 24.5M | 25.7M | |
Income Before Tax | (1.4M) | (4.0M) | (1.8M) | (10.4M) | (16.8M) | (16.0M) | |
Net Income | (1.7M) | (3.7M) | (1.8M) | (9.9M) | (16.8M) | (15.9M) | |
Income Tax Expense | 210K | 62K | 261K | (297K) | (267.3K) | (253.9K) | |
Tax Provision | 261K | (297K) | 217K | (484K) | (11K) | (11.6K) | |
Net Interest Income | 59K | 328K | 2K | (76K) | (284K) | (269.8K) | |
Ebitda | 911K | (2.0M) | 1.4M | (5.3M) | (4.7M) | (4.5M) |
Nanalysis Scientific Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | 5.8M | (3.5M) | 7.2M | (6.9M) | (2.8M) | (2.6M) | |
Net Borrowings | (144K) | 81K | 1.0M | 1.2M | 1.3M | 1.4M | |
Depreciation | 547K | 790K | 857K | 4.6M | 4.7M | 4.9M | |
Capital Expenditures | 545K | 427K | 595K | 7.2M | 4.6M | 4.8M | |
Net Income | (1.7M) | (3.7M) | (1.8M) | (9.1M) | (16.8M) | (15.9M) | |
Change To Netincome | 324K | 549K | 6K | 569K | 512.1K | 355.4K | |
End Period Cash Flow | 6.6M | 3.2M | 10.4M | 3.5M | 759K | 721.1K | |
Investments | (3.1M) | (4.1M) | (3.3M) | (11.7M) | (6.1M) | (6.4M) | |
Free Cash Flow | (2.4M) | (3.5M) | (4.2M) | (15.6M) | (15.8M) | (15.0M) | |
Other Non Cash Items | (102K) | (113K) | (22K) | 152K | (504K) | (478.8K) |
Nanalysis Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nanalysis Scientific's current stock value. Our valuation model uses many indicators to compare Nanalysis Scientific value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nanalysis Scientific competition to find correlations between indicators driving Nanalysis Scientific's intrinsic value. More Info.Nanalysis Scientific Corp is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nanalysis Scientific's earnings, one of the primary drivers of an investment's value.Nanalysis Scientific Corp Systematic Risk
Nanalysis Scientific's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Nanalysis Scientific volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Nanalysis Scientific Corp correlated with the market. If Beta is less than 0 Nanalysis Scientific generally moves in the opposite direction as compared to the market. If Nanalysis Scientific Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Nanalysis Scientific Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Nanalysis Scientific is generally in the same direction as the market. If Beta > 1 Nanalysis Scientific moves generally in the same direction as, but more than the movement of the benchmark.
Nanalysis Scientific Corp Total Assets Over Time
Nanalysis Scientific December 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Nanalysis Scientific help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Nanalysis Scientific Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Nanalysis Scientific Corp based on widely used predictive technical indicators. In general, we focus on analyzing Nanalysis Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Nanalysis Scientific's daily price indicators and compare them against related drivers.
Information Ratio | (0.08) | |||
Maximum Drawdown | 18.04 | |||
Value At Risk | (5.41) | |||
Potential Upside | 5.41 |
Additional Tools for Nanalysis Stock Analysis
When running Nanalysis Scientific's price analysis, check to measure Nanalysis Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanalysis Scientific is operating at the current time. Most of Nanalysis Scientific's value examination focuses on studying past and present price action to predict the probability of Nanalysis Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanalysis Scientific's price. Additionally, you may evaluate how the addition of Nanalysis Scientific to your portfolios can decrease your overall portfolio volatility.